Literature DB >> 835384

Morphological changes in anaplastic gliomas treated with radiation and chemotherapy.

L Gerstner, K Jellinger, W D Heiss, G Wöber.   

Abstract

The effects of antineoplastic treatment on gliomas are related to tumour cell cycle and proliferation kinetics, glioma tissue architecture, and the surrounding environment. Morphological changes induced by radiation and chemotherapy are characterized by cell necrosis and severe alterations in cell and nuclear morphology caused by changes in the cell kinetic parameters which, however, may also occur spontaneously in untreated anaplastic gliomas. Comparative studies of cytological imprints and routine histological preparations of biopsy and autopsy specimens were performed in four groups of anaplastic astrocytomas and glioblastomas (78 cases) with postsurgical irradiation, combination chemotherapy, and CCNU treatment, and without specific postsurgical treatment (control group). Following radiation and chemotherapy, in addition to increased necrosis and vascular response, a variety of characteristic but nonspecific changes were observed in cell and nuclear morphology with prominent formation of multinucleated giant and monstrous cells, irregular and hyperchromatic nuclei, and severe cytoplasmic degeneration indicating both inhibition of cell division and cell damage. Statistically significant findings were a posttreatment increase in the number of multinucleated giant and monstrous cells and a decrease in the number of mitoses. These changes were more pronounced after chemotherapy than after radiation, while no significant dissimilarities were found between combination chemotherapy and CCNU. The implications of these changes on the mechanisms of antitumour treatment in anaplastic gliomas are discussed.

Entities:  

Mesh:

Year:  1977        PMID: 835384     DOI: 10.1007/BF01405993

Source DB:  PubMed          Journal:  Acta Neurochir (Wien)        ISSN: 0001-6268            Impact factor:   2.216


  29 in total

Review 1.  Vascular structures in brain tumors.

Authors:  A Hirano; T Matsui
Journal:  Hum Pathol       Date:  1975-09       Impact factor: 3.466

2.  Review of selected experimental brain tumor models used in chemotherapy experiments.

Authors:  P C Merker; I Wodinsky; R I Geran
Journal:  Cancer Chemother Rep       Date:  1975 Jul-Aug

3.  Analysis of the effects of antitumor drugs on cell cycle kinetics.

Authors:  K B Woo; L B Brenkus; K M Wiig
Journal:  Cancer Chemother Rep       Date:  1975 Jul-Aug

4.  Cell kinetics of human gliomas.

Authors:  T Hoshino; M Barker; C B Wilson; E B Boldrey; D Fewer
Journal:  J Neurosurg       Date:  1972-07       Impact factor: 5.115

Review 5.  The kinetics of tumour cell proliferation and radiotherapy.

Authors:  M Tubiana
Journal:  Br J Radiol       Date:  1971-05       Impact factor: 3.039

Review 6.  Proliferation-dependent cytotoxicity of anticancer agents: a review.

Authors:  F Valeriote; L van Putten
Journal:  Cancer Res       Date:  1975-10       Impact factor: 12.701

7.  Controlled study of CCNU and radiation therapy in malignant astrocytoma.

Authors:  T J Reagan; H F Bisel; D S Childs; D D Layton; A L Rhoton; W F Taylor
Journal:  J Neurosurg       Date:  1976-02       Impact factor: 5.115

8.  An electron-microscope study of the mode of cell death induced by cancer-chemotherapeutic agents in populations of proliferating normal and neoplastic cells.

Authors:  J Searle; T A Lawson; P J Abbott; B Harmon; J F Kerr
Journal:  J Pathol       Date:  1975-07       Impact factor: 7.996

9.  Perivascular lymphocytic cuffing in astrocytomas.

Authors:  J Takeuchi; R O Barnard
Journal:  Acta Neuropathol       Date:  1976       Impact factor: 17.088

10.  [Frequency and significance of lymphoplasmocyte infiltration in human gliomas (author's transl)].

Authors:  D Schiffer; G Croveri; C Pautasso
Journal:  Tumori       Date:  1974 May-Jun
View more
  9 in total

1.  Effects of radiotherapy on the astrocytomatous areas of malignant gliomas.

Authors:  D Schiffer; M T Giordana; R Soffietti; R Sciolla; G L Sannazzari; E Vasario
Journal:  J Neurooncol       Date:  1984       Impact factor: 4.130

2.  Radio- and chemotherapy of malignant gliomas. Pathological changes in the normal nervous tissue.

Authors:  D Schiffer; M T Giordana; R Soffietti; L Tarenzi; R Milani; E Vasario; P Paoletti
Journal:  Acta Neurochir (Wien)       Date:  1981       Impact factor: 2.216

3.  Pathology of human malignant gliomas after radiation and chemotherapy.

Authors:  D Schiffer; M T Giordana; P Paoletti; R Soffietti; L Tarenzi
Journal:  Acta Neurochir (Wien)       Date:  1980       Impact factor: 2.216

4.  Malignant gliomas treated after surgery by combination chemotherapy and delayed irradiation. Part I: Analysis of results.

Authors:  M Poisson; P Pouillart; J P Bataini; R Mashaly; B F Pertuiset; J Metzger
Journal:  Acta Neurochir (Wien)       Date:  1979       Impact factor: 2.216

5.  Malignant gliomas treated after surgery by combination chemotherapy and delayed radiation therapy. Part II. Tolerance to irradiation after chemotherapy.

Authors:  M Poisson; J J Hauw; P Pouillart; J P Bataini; R Mashaly; B F Pertuiset; J Metzger
Journal:  Acta Neurochir (Wien)       Date:  1979       Impact factor: 2.216

6.  Histological observations on the regrowth of malignant gliomas after radiotherapy and chemotherapy.

Authors:  D Schiffer; M T Giordana; R Soffietti; R Sciolla
Journal:  Acta Neuropathol       Date:  1982       Impact factor: 17.088

7.  Chemotherapy of malignant gliomas: comparison of the effect of polychemo- and CCNU-therapy.

Authors:  W D Heiss
Journal:  Acta Neurochir (Wien)       Date:  1978       Impact factor: 2.216

8.  Flow-through fluorocytophotometry of different brain tumours.

Authors:  J Lehmann; H Krug
Journal:  Acta Neuropathol       Date:  1980       Impact factor: 17.088

9.  Cerebral space-occupying cysts following radiation and chemotherapy of malignant gliomas.

Authors:  D Volc; K Jellinger; H Flament; F Böck; J Klumair
Journal:  Acta Neurochir (Wien)       Date:  1981       Impact factor: 2.216

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.